文献速递产科母胎医学

肝硬化孕妇的医学与产科并发症

Medical and Obstetric Complications Among Pregnant Women With Liver Cirrhosis.
PubMed 文献 · Obstet Gynecol · 2017-01-01

这项回顾性匹配队列研究纳入2005年1月至2016年1月某大学医院31例肝硬化孕妇,按分娩年份、年龄、体重指数及产次以1:4匹配对照组,比较复合不良结局发生率;肝硬化组为61%,对照组为12%,多因素分析显示肝硬化与复合结局相关(调整比值比9.4,95%CI 3.4-26.2)。

要点

  • 肝硬化孕妇复合不良产科结局发生率为61%,对照组为12%。
  • 多因素分析显示妊娠期肝硬化与复合结局相关,调整比值比9.4(95%CI 3.4-26.2)。
  • 未发生孕产妇死亡,活产率为97%。

核心结论

  • 尽管孕产妇和胎儿死亡率较早期研究降低,肝硬化孕妇的妊娠仍与不良产科结局高风险相关。

研究设计与样本

  • 回顾性匹配队列研究,纳入2005年1月至2016年1月某大学医院肝硬化孕妇,按分娩年份、年龄、体重指数及产次以1:4匹配对照组。
  • 研究期间分娩约110,000例,识别33例肝硬化孕妇,估计肝硬化发生率为每3,333次妊娠1例(95%CI 3,313-3,353)。
  • 33例中31例符合全部纳入标准。

主要发现

  • 肝硬化最常见的病因为酒精性肝病。
  • 复合主要结局发生率肝硬化组为61%,对照组为12%。
  • 未发生孕产妇死亡,活产率为97%。
  • 肝硬化孕妇更可能为非西班牙裔黑人、患慢性高血压及饮酒。
  • 多因素logistic回归显示妊娠期肝硬化与复合结局相关(调整比值比9.4,95%CI 3.4-26.2)。

关键数值与推荐

  • 主要复合结局包括以下任一:胎儿或新生儿死亡、胎盘早剥、子痫前期、小于37周早产及小于胎龄儿。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate clinical characteristics and obstetric outcomes in pregnant women with liver cirrhosis. METHODS: This was a retrospective matched cohort study of women with liver cirrhosis between January 2005 and January 2016 in a university hospital. Women in a case group were matched to women in a control group according to year of delivery, age, body mass index, and parity in a 1:4 ratio. Bivariable and multivariable analyses were performed to compare the prevalence of the primary composite outcome, which included any one of the following: fetal or neonatal demise, placental abruption, preeclampsia, preterm delivery at less than 37 weeks of gestation, and small-for-gestational age neonate between women in the case group and those in the control group. RESULTS: During the study period, the number of deliveries was approximately 110,000. Of these, 33 women with liver cirrhosis were identified, yielding an estimated frequency of cirrhosis of 1 per 3,333 pregnancies [95% confidence interval (CI) 3,313-3,353]. Thirty-one of these 33 women met all inclusion criteria. The most common etiology of cirrhosis was alcoholic liver disease. The rate of the primary outcome was 61% in women with cirrhosis and 12% in women in the control group. There were no cases of maternal death, and the livebirth rate was 97%. Women with cirrhosis were more likely to be non-Hispanic black, have chronic hypertension, and use alcohol. Multivariable logistic regression demonstrated that cirrhosis in pregnancy was associated with the composite outcome (adjusted odds ratio 9.4, 95% CI 3.4-26.2). CONCLUSION: Despite lower rates of maternal and fetal mortality compared with earlier studies, pregnancy in women with liver cirrhosis is still associated with a high risk of adverse obstetric outcomes.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Palatnik A, Rinella ME. Medical and Obstetric Complications Among Pregnant Women With Liver Cirrhosis. Obstet Gynecol. 2017. PMID: 28486373. doi:10.1097/AOG.0000000000002055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。